Compare Adaptive Biotechnologies Corp (ADPT) vs Flagstar Bank NA (FLG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Flagstar Bank NA — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Flagstar Bank NA trades at $14.23 (market cap $5.89B). The key difference: Flagstar Bank NA is the larger of the two by market cap, and Flagstar Bank NA pays a 0.28% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | FLG | |
|---|---|---|
Market Cap | $4.04B | $5.89B |
Sector | Health | Financials |
52-Week High | $25.45 | $15.36 |
52-Week Low | $12.30 | $10.72 |
Enterprise Value | $4.10B | — |
Dividend Yield | — | 0.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →
